On 5 February, GlobalSCAPE, Inc. (NYSEMKT: GSB) announced the initiation of a quarterly cash dividend program commencing the second quarter of 2015. The initial cash dividend will be $0.015 per share with the applicable second quarter record and payment dates to be determined. On Tuesday shares of GlobalSCAPE, Inc. (NYSEMKT: GSB) closed at $3.06. Company’s sales growth for last 5 years was 9.00%.
EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) announced that the Company is scheduled to present a corporate overview at the Leerink Global Healthcare Conference in New York City on Thursday, February 12, 2015 at 11:35 a.m. Eastern Time. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in last trading activity advanced 5.72% to close at $5.91. Company weekly performance is 18.20% while its quarterly performance stands at 31.04%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) is -66.03% away from its 52 week high.
On 4 February, Iteris, Inc. (NYSEMKT: ITI) announced that BASF has entered into an agreement to leverage Iteris’ ClearAg high-resolution field level weather information. On last trading day Iteris, Inc. (NYSEMKT: ITI) moved down -2.67% to close at $1.82. Its volatility for the week is 4.10% while volatility for the month is 2.96%. ITI’s sales growth for past 5 years was -0.30% and its EPS growth for past 5 years was -33.20%. Iteris, Inc. (NYSEMKT:ITI) monthly performance is 6.43%.
On 4 February, Amedica Corporation (NASDAQ:AMDA) announced that the U.S. Food and Drug Administration (FDA) has expanded the indications of Amedica’s silicon nitride interbody fusion products to include multi-level cervical treatment. Amedica Corporation (NASDAQ:AMDA) has 1.50% insider ownership while its institutional ownership stands at 13.60%. In last trading activity company’s stock closed at $0.65.
Biocept, Inc. (NASDAQ:BIOC) announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock and warrants to purchase up to an aggregate of 8,000,000 shares of its common stock at a combined offering price of $1.25. On last trading day Biocept, Inc. (NASDAQ:BIOC) moved down -33.51% to close at $1.23. Its volatility for the week is 22.24% while volatility for the month is 15.49%. Biocept, Inc. (NASDAQ:BIOC) monthly performance is -62.15%.